Heart failure: When form fails to follow function

European Heart Journal

Volumn 37, Issue 5, 2016, Pages 449-454

  Katz, Arnold M ^a,b   Rolett, Ellis L ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Cardiac architecture; Ejection fraction; Heart failure; Hypertrophic signalling; Sarcomere addition

Indexed keywords

CHIMERA; CYTOSKELETON; DIASTOLIC HEART FAILURE; ENERGY COST; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HEART STROKE VOLUME; HUMAN; MECHANICAL STRESS; MUSCLE CELL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOMERE; SIGNAL TRANSDUCTION; SYSTOLIC HEART FAILURE; VENOUS RETURN; CARDIOMYOPATHY, DILATED; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HEART VENTRICLE; HEART VENTRICLE FUNCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

CYTOSKELETON PROTEIN;

CARDIOMYOPATHY, DILATED; CYTOSKELETAL PROTEINS; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HEART VENTRICLES; HUMANS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; STROKE VOLUME; VENTRICULAR DYSFUNCTION;

EID: 84960173063     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv548     Document Type: Review

References (60)

1. Sullivan LH. The Tall Office Building Artistically Considered. Lippincott s Monthly Magazine. Philadelphia: J.B. Lippincott Co., 1896, pp. 403-409.
2. Konstam MA. Systolic and diastolic dysfunction in heart failure? Time for a new paradigm. J Card Fail. 2003; 9: 1-3.
3. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail. 2012; 14: 803-869.
4. Ingwall JS. Energy metabolism in heart failure and remodeling. Cardiovasc Res 2009. 81: 412-419.
5. Breasted JH. The Edwin Smith Surgical Papyrus. Chicago: University of Chicago Press. 1930.
6. Katz AM, Katz PB. Homogeneity out of heterogeneity. Circulation. 1989; 79: 712-717.
7. Russell B, Motlagh D, Ashley WW. Form follows function: how muscle shape is regulated by work. J Appl Physiol. 2000; 88: 1127-1132.
8. Corvisart JN. An Essay on the Organic Diseases and Lesions of the Heart and Great Vessels, transl. J. Gates. Boston: Bradford and Read. 1812.
9. Hope J A Treatise on the Diseases of the Heart and Great Vessels. 4th ed. London: Churchill. 1849.
10. Paul C. Diagnosis and Treatment of Diseases of the Heart. New York: Wood. 1884.
11. Starr I Jr, Collins LH Jr,Wood FC. Studies of the basal work and output of the heart in clinical conditions. J Clin Invest. 1933; 12: 13-43.
12. Lysholm E, Nylin G, Quarna K. The relation between heart volume and stroke volume under physiological and pathological conditions. Acta Radiol. 1934; 15: 237-257.
13. Arvidsson H. Angiographic determination of left ventricular volume. Acta Radiol. 1961; 56: 321-339.
14. Gorlin R, Rolett EL, Yurchak PM, Elliott WC. Left ventricular volume in man measured by thermodilution. J Clin Invest. 1964; 43: 1203-1221.
15. Kennedy JW, Baxley WA, Figley MM, Dodge HT, Blackmon JR. Quantitative angiography. I. The normal left ventricle in man. Circulation. 1966; 34: 272-278.
16. Folland ED, Hamilton GW, Larson SM, Kennedy JW, Williams DL, Richie JL. The radionuclide ejection fraction: a comparison of three radionuclide techniques with contrast angiography. J Nucl Med. 1977; 18: 1159-1166.
17. Pombo JF, Troy BL, Russell RO Jr. Left ventricular volumes and ejection fraction by echocardiography. Circulation. 1971; 43: 480-490.
18. Katz AM. Regulation of cardiac muscle contractility. J Gen Physiol. 1967; 50: 185-196.
19. Katz AM, Repke DI. Quantitative aspects of dog cardiac microsomal calcium binding and calcium uptake. Circ Res. 1967; 21: 153-162.
20. Miller GAH, Kirklin JW, Swan HJC. Myocardial function and left ventricular volumes in acquired valvular insufficiency. Circulation. 1965; 31: 374-383.
21. Dodge HT, Sandler H, Baxley WA, Hawley RR. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol. 1966; 18: 10-24.
22. Krayenbühl HP, Bussmann WD, Turina M, Lüthy E. Is the ejection fraction an index of myocardial contractility? Cardiologia. 1968; 53: 1-10.
23. Kreulen TH, Bove AA, McDonough MT, McDonough MT, Sands MJ, Spann JF. The evaluation of left ventricular function in man A comparison of methods. Circulation. 1977; 51: 677-688.
24. Drake-Holland AJ, Mills CJ, Noble MIM, Pugh S. Responses to changes in filling and contractility of indices of human left ventricular mechanical performance. J Physiol (Lond) 1990; 422: 29-39.
25. Gill RM, Jones BD, Corbly AK, Ohad DG, Smith GD, Sandusky GE, Christie ME, Wang J, Shen W. Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure induced by chronic coronary microembolization. Life Sci 2006. 79: 536-544.
26. Fishberg AM. Heart Failure. Philadelphia: Lea & Febiger. 1937.
27. von Niemeyer F A Text-Book of Practical Medicine. 3rd American ed. transl. Humphreys GH, Hackley CE. New York: Appleton. 1870.
28. Fothergill JM. The Heart and its Diseases with their Treatment: Including the Gouty Heart. 2nd ed. London: H.K. Lewis. 1879.
29. Sandler H, Dodge HT. Left ventricular tension and stress in man. Circ Res. 1963; 13: 91-104.
30. Hood WP Jr, Rackley CE, Rolett EL. Wall stress in the normal and hypertrophied human left ventricle. Am J Cardiol. 1968; 22: 550-558.
31. Grant C, Greene DG, Bunnell IL. Left ventricular enlargement and hypertrophy A clinical and angiographic study. Am J Med. 1965; 39: 895-904.
32. Gerdes AM. Cardiac myocyte remodeling in hypertrophy and progression to failure. J Card Fail. 2002; 8: S264-S268.
33. Meerson FZ. On the mechanism of compensatory hyperfunction and insufficiency of the heart. Cor Vasa. 1961; 3: 161-177.
34. Katz AM. Cardiomyopathy of overload A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990; 322: 100-110.
35. Schiaffino S: Myosin types and fiber types in cardiac muscle: I. Ventricular myocardium. J Cell Biol. 1981; 88: 226-233.
36. Bouvagnet P, Leger J, Dechesne C, Pons F, Leger JJ. Fiber types and myosin types in human atrial and ventricular myosin: an anatomical description. Circ Res. 1984; 55: 794-804.
37. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS. Pressure- And volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995; 92: 2385-2390.
38. Toischer K, Rokita AG, Unsöld B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lenhart SE, Krüger M, Linke WA, Backs J, Regita-Zagrosek V, Field LJ, Maier LS, Hasefuss G. Differential cardiac remodeling in preload versus afterload. Circulation. 2010; 122: 993-1003.
39. Hill JA, Olson EN. Cardiac plasticity. New Engl J Med. 2008; 358: 1370-1380.
40. Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet. 2011; 378: 704-712.
41. van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathological growth and remodeling of the heart. J Clin Invest. 2013; 123: 37-45.
42. Krüger M, Linke WA. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol. 2009; 46: 490-498.
43. Lichter JG, Carruth E, Mitchell C, Barth AS, Aiba T, Kass DA, Tomaselli GF, Bridge JH, Sachse FB. Remodeling of the sarcomeric cytoskeleton in cardiac ventricular myocytes during heart failure and after cardiac resynchronization therapy. J Mol Cell Cardiol. 2014; 72: 186-195.
44. Wilson AJ, Schoenauer R, Ehler E, Agarkova I, Bennett PM. Cardiomyocyte growth and sarcomerogenesis at the intercalated disc. Cell Mol Life Sci. 2014; 71: 165-181.
45. Russell B, Curtis MW, Koshman YE, Samarel AM. Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width. J Mol Cell Cardiol. 2010; 48: 817-823.
46. Ehrlicher AJ, Nakamura F, Hartwig JH, Weitz DA, Stossel TP. Mechanical strain in actin networks regulates FilGAP and integrin binding to filamin A. Nature. 2011; 478: 260-263.
47. Manso AM, Li R, Monkley SJ, Cruz NM, Ong S, Lao DH, Koshman YE, Gu Y, Peterson KL, Chen J, Abel ED, Samarel AM. Talin 1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload. J Biol Chem. 2013; 288: 4252-4264.
48. Ryall KA, Bezzerides VJ, Rosenzweig A, Saucerman JJ. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. J Mol Cell Cardiol. 2014; 72: 74-84.
49. Haggart CR, Ames EG, Lee JK, Holmes JW. Effects of stretch and shortening on gene expression in intact myocardium. Physiol Genomics. 2014; 46: 57-65.
50. Little WC. Heart failure with a normal left ventricular ejection fraction: diastolic heart failure. Trans Am Clin Climatol Assoc. 2008; 119: 93-99.
51. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355: 251-259.
52. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D. Relation of disease etiology and risk factors to heart failure with preserved or reduced ejection fraction: insights from the National Heart, Lung, and Blood institute s Framingham Heart Study. Circulation. 2009; 119: 3070-3077.
53. Hein S, Arnon E, Kostin S, Schönburg M, Elsässer A, Polyakova V, Bauer EP, Klövkorn WP, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003; 107: 984-991.
54. Rockey DC, Bell PD, Hill JA. Fibrosis - A common pathway to organ injury and failure. New Engl J Med. 2015; 372: 1138-1149.
55. Sharma K, Kass D. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res. 2014; 115: 79-96.
56. Mann DL, Barger P, Burkhoff D. Myocardial recovery and the failing heart: myth, magic, or molecular target. J Am Coll Cardiol. 2012; 60: 2465-2472.
57. Krishnamoorthy A, Brown T, Ayers CR, Gupta S, Rame JE, Patel PC, Markham DW, Drazner MH. Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-Term follow-up. Am J Cardiol. 2011; 108: 997-1001.
58. Shah AM. Ventricular remodeling in heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013; 10: 341-349.
59. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013; 9: 531-547.
60. Arbustini E, Weidemann F, Hall JL. Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases. J Am Coll Cardiol 2014. 64: 1840-1850.